AI assistant
Sending…
ARTIVION, INC. — Director's Dealing 2018
Feb 15, 2018
31684_dirs_2018-02-15_e3e04b1e-2df5-4d28-a2d1-bf05bf4e13ba.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CRYOLIFE INC (CRY)
CIK: 0000784199
Period of Report: 2018-02-13
Reporting Person: Capps Scott B (VP, Clinical Research)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-02-13 | Common Stock | F | 9381 | $17.1 | Disposed | 104261 | Direct |
| 2018-02-13 | Common Stock | M | 31333 | $5.12 | Acquired | 135594 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-02-13 | Stock Options (Right to Buy) | $5.12 | M | 31333 | Disposed | 2018-02-23 | Common Stock (31333) | Direct |
Footnotes
F1: Payment of exercise by delivering shares in accordance to Rule 16b-3.
F2: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/23/2012
More from ARTIVION, INC.
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3